$3,495.00

Essential Benchmark Data for Dealmakers - The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments.

Publication date
April 2020
Number of pages
450+
Product type
Research report
Available formats
PDF document
Report edition
3
SKU
CP2013